Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131644) titled 'A multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial on the efficacy and safety of brivaracetam tablets in the treatment of partial epileptic seizures' on Sept. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
Epilepsy
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2025-10-30
Target Sample Size: Experimental group:194;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=287707
Published by HT Digital Content Services with...